UPClytics
View all cases

UPC CFI 98/2026

Jan 12, 2026·EP2493466 · NOVEL ANTITUMORAL USE OF CABAZITAXEL

Case details
Status
Case Closed
Action
Other
Category
Other procedural
Parties
Claimants
Representatives
Respondents
Representatives
  • Anja Lunze
Division
Munich LD
Technology
  • Chemistry
    Pharmaceuticals
Language
English
EPO Opposition
How this compares
How long the court takes to reach a first decision.
Median days to first decision
All UPC124
Munich LDLocked
Judge Matthias ZigannLocked
Judge Tobias PichlmaierLocked
Judge Alima ZanaLocked

At the UPC: Sanofi Group (33 cases)·Zentiva Group (15 cases)

This dispute contains 9 other proceedings

UPC CoA 24/2026·UPC CoA 27/2026·UPC CFI 99/2026·UPC CFI 503/2024·UPC CFI 148/2024 and 4 more

10 other defendants litigating the same or a related patent

UPC CoA 22/2026·UPC CoA 23/2026·UPC CoA 25/2026·UPC CoA 26/2026·UPC CFI 496/2024 and 5 more

Start a free trial to see how each one ended.

More cases: Munich LD·2026

Documents
Document titleDatePublic
Publication2026-02-23Not public
Order2026-02-03Public
Case closed2026-02-03Not public
Decision2026-02-03Not public
Decision2026-02-03Not public
Receipt2026-02-02Not public
Cover sheet2026-02-02Not public
Other document Respondent2026-02-02Not public
Communication2026-01-16Not public
Receipt2026-01-12Not public
Cover sheet2026-01-12Not public
Exhibit document Respondent2026-01-12Not public
Exhibit document Respondent2026-01-12Not public
Exhibit document Respondent2026-01-12Not public
Exhibit document Respondent2026-01-12Not public
Application document Respondent2026-01-12Not public